Company Profile | ![]() | 0-9 | ![]() | A | ![]() | B | ![]() | C | ![]() | D | ![]() | E | ![]() | F | ![]() | G | ![]() | H | ![]() | I | ![]() | J | ![]() | K | ![]() | L | ![]() | M | ![]() | N | ![]() | O | ![]() | P | ![]() | Q | ![]() | R | ![]() | S | ![]() | T | ![]() | U | ![]() | V | ![]() | W | ![]() | X | ![]() | Y | ![]() | Z |
WPP plc
(NYSE: WPP)
|
8:00 PM UTC, 04/23/25 | |||
---|---|---|---|---|
Last: $36.46 | Change: +0.42 | %Change: +1.17% | Volume: 245,087 |
11:12 AM EST, 03/06/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.61% to 1,444.24 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by Sequans Communications (SQNS) and financial services company ING Groep (ING), which rose 6.8% and 4.2% respectively. They were followed by financial services company Banco Santander (SAN) and biopharmaceutical company Genfit (GNFT), which were up 2.2% each.
The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and pharmaceutical company Novo Nordisk (NVO), which fell 3.7% and 2.1% respectively. They were followed by biotech firm BioNTech (BNTX) and biopharmaceutical company Cellectis (CLLS), which lost 1.9% and 1.3% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm (TCBP) and Akari Therapeutics (AKTX), which advanced 16.7% and 8.8% respectively. They were followed by communications company WPP (WPP) and biopharmaceutical company Verona Pharma (VRNA), which increased 3.5% and 1.7% respectively.
The decliners from the UK and Ireland were led by educational publisher Pearson (PSO) and hospitality company InterContinental Hotels Group (IHG), which dropped 3.6% and 3.1% respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and cruise line operator Carnival (CUK), which were down 5% and 2.9% respectively.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.